 | Milind Deshpande
male
(New York City Area, United States)
Dr. Deshpande joined Achillion in September 2001 as Vice President of Chemistry, was named Head of Drug Discovery in April 2002, Senior Vice... |
 | Milind S. Deshpande
male
Milind Deshpande Ph.D. Executive Vice President and Chief Scientific Officer Dr. Deshpande brings to Achillion over 15 years experience working... |
 | William G. Rice
male
William G. Rice , Ph.D. President and Chief Executive Officer Dr. Rice serves as Cylenes President and CEO and as a Director. Dr. Rice jo... |
 | Gautam Shah
male
Dr. Shah joined Achillion in May 2004 as Vice President of Regulatory Affairs and was named Senior Vice President and Chief Compliance Officer in... |
 | Mary Kay Fenton
female
Ms. Fenton, a certified public accountant, has led Achillion's financial function since October 2000. From 1991 to 2000, Ms. Fenton held various... |
 | Kevin L. Eastwood
male
Kevin L. Eastwood Vice President, Corporate Development Prior to joining Ambrx, Mr. Eastwood was the Senior Vice President of Business... |
| | Stephen K. Carter Md
male
Stephen K. Carter, M.D. has served on our Board of Directors since September 1998. Since 1997, Dr. Carter has been a consultant to the... |
| | Michael G. Grey
male
Michael G. Grey Mr. Grey previously served as a director for Epimmune and since January 1, 2005 , he has served as President and Chief Executive... |
| | Jason Fisherman
male
Jason Fisherman , M.D., has been a director of TorreyPines since 2000. He is a Senior Vice President of Advent International Corporation, a global... |
| | David Scheer
male
David Scheer Chairman of the Board of Directors of Tengion President of Scheer & Company Mr. Scheer possesses more than two decades of... |
| |
